
Delxone TZ 500mg/62.5mg Injection
Marketer
Dr. Edwin Lab
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Delxone TZ 500mg/62.5mg Injection
Combixine 500mg/62.5mg Injection, a dual-action medication, combats various bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be under medical guidance; adhere strictly to the prescribed dosage schedule. Complete the full course, even with symptom improvement; premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Sufficient rest, proper nutrition, and hydration promote faster recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Delxone TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Delxone TZ 500mg/62.5mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Delxone TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Delxone TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Delxone TZ 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Delxone TZ 500mg/62.5mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. The beta-lactamase inhibitor, Tazobactum, complements this action by countering bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of Delxone TZ 500mg/62.5mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation Delxone TZ 500mg/62.5mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Administering Delxone TZ 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Delxone TZ 500mg/62.5mg Injection can lead to reduced attentiveness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Delxone TZ 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The use of Delxone TZ 500mg/62.5mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Delxone TZ 500mg/62.5mg Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Delxone TZ 500mg/62.5mg Injection :
Should you forget a scheduled dose of Delxone TZ 500mg/62.5mg Injection, seek advice from your physician.
Facts to Know About Delxone TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
